Medical Costs by Disease Stage in Medicare Patients with Metastatic Melanoma

Journals Menu

Follow SCIRP

	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Journal of Cancer Therapy

ISSN Print: 2151-1934
ISSN Online: 2151-1942
www.scirp.org/journal/jct
E-mail: jct@scirp.org

Citations

Journals Menu

"Medical Costs by Disease Stage in Medicare Patients with Metastatic Melanoma"
written by Amanda M. Farr, Zhongyun Zhao, Xue Song, Beth Barber, Boris Ivanov, Marilyn Novich,
published by Journal of Cancer Therapy, Vol.8 No.11, 2017

has been cited by the following article(s):

Google Scholar
CrossRef

[1]	An evaluation of the role of locoregional treatments for the management of in-transit melanoma metastases
	2020

[2]	Promoting safe-sun behaviors in outdoor workers
	DISSERTATION, 2019

[3]	Economic modeling to evaluate the impact of chronic myeloid leukemia therapy management on the oncology care model in the US
	Journal of medical economics, 2019

Follow SCIRP

	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Journal of Cancer Therapy

Journal of Cancer Therapy

Journals Menu

Home

About SCIRP

Service

Policies

[1]	The economic burden of recurrence in elderly patients with completely resected, stage IIB/IIC or III melanoma: an analysis of the Surveillance, Epidemiology, and End Results-Medicare linked database Journal of Medical Economics, 2024 DOI:10.1080/13696998.2024.2403283

[2]	Economic modeling to evaluate the impact of chronic myeloid leukemia therapy management on the oncology care model in the US Journal of Medical Economics, 2019 DOI:10.1080/13696998.2019.1618316